nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—ABCC3—Glyburide—gestational diabetes	0.181	0.219	CbGbCtD
Methotrexate—SLC22A7—Glyburide—gestational diabetes	0.142	0.171	CbGbCtD
Methotrexate—ABCC1—Glyburide—gestational diabetes	0.111	0.134	CbGbCtD
Methotrexate—SLCO1A2—Glyburide—gestational diabetes	0.0994	0.12	CbGbCtD
Methotrexate—ABCC2—Glyburide—gestational diabetes	0.0824	0.0994	CbGbCtD
Methotrexate—ABCG2—Glyburide—gestational diabetes	0.0745	0.0899	CbGbCtD
Methotrexate—SLC22A6—Glyburide—gestational diabetes	0.0603	0.0727	CbGbCtD
Methotrexate—ALB—Glyburide—gestational diabetes	0.0514	0.0619	CbGbCtD
Methotrexate—ABCB1—Glyburide—gestational diabetes	0.0269	0.0324	CbGbCtD
Methotrexate—Allergic cutaneous angiitis—Glyburide—gestational diabetes	0.00669	0.092	CcSEcCtD
Methotrexate—Reaction gastrointestinal—Glyburide—gestational diabetes	0.00637	0.0877	CcSEcCtD
Methotrexate—Nephropathy—Glyburide—gestational diabetes	0.00447	0.0615	CcSEcCtD
Methotrexate—Leukocytoclastic vasculitis—Glyburide—gestational diabetes	0.00434	0.0597	CcSEcCtD
Methotrexate—ABCC11—embryo—gestational diabetes	0.00411	0.0524	CbGeAlD
Methotrexate—Eruption—Glyburide—gestational diabetes	0.00346	0.0476	CcSEcCtD
Methotrexate—Encephalopathy—Glyburide—gestational diabetes	0.00331	0.0456	CcSEcCtD
Methotrexate—FOLR1—uterus—gestational diabetes	0.00289	0.0369	CbGeAlD
Methotrexate—FPGS—islet of Langerhans—gestational diabetes	0.00259	0.033	CbGeAlD
Methotrexate—SLC19A1—adipose tissue—gestational diabetes	0.00248	0.0316	CbGeAlD
Methotrexate—ATIC—embryo—gestational diabetes	0.00242	0.0309	CbGeAlD
Methotrexate—Hyperbilirubinaemia—Glyburide—gestational diabetes	0.00234	0.0322	CcSEcCtD
Methotrexate—Vasculitis—Glyburide—gestational diabetes	0.00218	0.03	CcSEcCtD
Methotrexate—FOLR1—head—gestational diabetes	0.00217	0.0277	CbGeAlD
Methotrexate—Aplastic anaemia—Glyburide—gestational diabetes	0.002	0.0275	CcSEcCtD
Methotrexate—GGH—uterus—gestational diabetes	0.00192	0.0245	CbGeAlD
Methotrexate—SLC19A1—head—gestational diabetes	0.0019	0.0243	CbGeAlD
Methotrexate—GGH—adipose tissue—gestational diabetes	0.00188	0.024	CbGeAlD
Methotrexate—Hepatic failure—Glyburide—gestational diabetes	0.00172	0.0236	CcSEcCtD
Methotrexate—Renal failure acute—Glyburide—gestational diabetes	0.00167	0.023	CcSEcCtD
Methotrexate—FPGS—adipose tissue—gestational diabetes	0.00165	0.0211	CbGeAlD
Methotrexate—ATIC—uterus—gestational diabetes	0.00163	0.0208	CbGeAlD
Methotrexate—Visual disturbance—Glyburide—gestational diabetes	0.00163	0.0224	CcSEcCtD
Methotrexate—DHFR—embryo—gestational diabetes	0.00163	0.0207	CbGeAlD
Methotrexate—PGD—islet of Langerhans—gestational diabetes	0.00162	0.0206	CbGeAlD
Methotrexate—ATIC—adipose tissue—gestational diabetes	0.0016	0.0204	CbGeAlD
Methotrexate—GGH—vagina—gestational diabetes	0.00156	0.0199	CbGeAlD
Methotrexate—SLC46A1—head—gestational diabetes	0.00147	0.0187	CbGeAlD
Methotrexate—GGH—head—gestational diabetes	0.00144	0.0184	CbGeAlD
Methotrexate—AOX1—islet of Langerhans—gestational diabetes	0.00142	0.0182	CbGeAlD
Methotrexate—SLCO4C1—vagina—gestational diabetes	0.00138	0.0177	CbGeAlD
Methotrexate—FPGS—vagina—gestational diabetes	0.00137	0.0175	CbGeAlD
Methotrexate—SLCO1B3—vagina—gestational diabetes	0.00134	0.0172	CbGeAlD
Methotrexate—SLCO1C1—adipose tissue—gestational diabetes	0.00133	0.0169	CbGeAlD
Methotrexate—Eosinophilia—Glyburide—gestational diabetes	0.00132	0.0182	CcSEcCtD
Methotrexate—Pancreatitis—Glyburide—gestational diabetes	0.00131	0.018	CcSEcCtD
Methotrexate—Pancytopenia—Glyburide—gestational diabetes	0.00127	0.0174	CcSEcCtD
Methotrexate—FPGS—head—gestational diabetes	0.00127	0.0162	CbGeAlD
Methotrexate—ATIC—head—gestational diabetes	0.00123	0.0156	CbGeAlD
Methotrexate—Photosensitivity reaction—Glyburide—gestational diabetes	0.00122	0.0168	CcSEcCtD
Methotrexate—MTHFR—adipose tissue—gestational diabetes	0.00119	0.0151	CbGeAlD
Methotrexate—SLCO3A1—adipose tissue—gestational diabetes	0.00117	0.0149	CbGeAlD
Methotrexate—Agranulocytosis—Glyburide—gestational diabetes	0.00111	0.0153	CcSEcCtD
Methotrexate—DHFR—uterus—gestational diabetes	0.0011	0.014	CbGeAlD
Methotrexate—TYMS—adipose tissue—gestational diabetes	0.00108	0.0138	CbGeAlD
Methotrexate—SLC19A1—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.00108	0.0557	CbGpPWpGaD
Methotrexate—DHFR—adipose tissue—gestational diabetes	0.00107	0.0137	CbGeAlD
Methotrexate—Hepatitis—Glyburide—gestational diabetes	0.00107	0.0147	CcSEcCtD
Methotrexate—PGD—uterus—gestational diabetes	0.00105	0.0134	CbGeAlD
Methotrexate—PGD—adipose tissue—gestational diabetes	0.00103	0.0131	CbGeAlD
Methotrexate—Visual impairment—Glyburide—gestational diabetes	0.00103	0.0142	CcSEcCtD
Methotrexate—SLCO1C1—head—gestational diabetes	0.00102	0.013	CbGeAlD
Methotrexate—Eye disorder—Glyburide—gestational diabetes	0.000999	0.0137	CcSEcCtD
Methotrexate—SLC16A1—uterus—gestational diabetes	0.000983	0.0125	CbGeAlD
Methotrexate—SLCO3A1—vagina—gestational diabetes	0.00097	0.0124	CbGeAlD
Methotrexate—SLC16A1—adipose tissue—gestational diabetes	0.000962	0.0123	CbGeAlD
Methotrexate—Alopecia—Glyburide—gestational diabetes	0.000944	0.013	CcSEcCtD
Methotrexate—Malnutrition—Glyburide—gestational diabetes	0.00093	0.0128	CcSEcCtD
Methotrexate—Erythema—Glyburide—gestational diabetes	0.00093	0.0128	CcSEcCtD
Methotrexate—AOX1—uterus—gestational diabetes	0.000928	0.0118	CbGeAlD
Methotrexate—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.000918	0.0473	CbGpPWpGaD
Methotrexate—MTHFR—head—gestational diabetes	0.000911	0.0116	CbGeAlD
Methotrexate—AOX1—adipose tissue—gestational diabetes	0.000908	0.0116	CbGeAlD
Methotrexate—ABCC10—uterus—gestational diabetes	0.000903	0.0115	CbGeAlD
Methotrexate—TYMS—vagina—gestational diabetes	0.0009	0.0115	CbGeAlD
Methotrexate—SLCO3A1—head—gestational diabetes	0.000896	0.0114	CbGeAlD
Methotrexate—DHFR—vagina—gestational diabetes	0.000891	0.0114	CbGeAlD
Methotrexate—ABCC3—adipose tissue—gestational diabetes	0.000888	0.0113	CbGeAlD
Methotrexate—ABCC10—adipose tissue—gestational diabetes	0.000883	0.0113	CbGeAlD
Methotrexate—Vision blurred—Glyburide—gestational diabetes	0.000877	0.0121	CcSEcCtD
Methotrexate—Anaemia—Glyburide—gestational diabetes	0.00086	0.0118	CcSEcCtD
Methotrexate—PGD—vagina—gestational diabetes	0.000856	0.0109	CbGeAlD
Methotrexate—Leukopenia—Glyburide—gestational diabetes	0.000833	0.0115	CcSEcCtD
Methotrexate—TYMS—head—gestational diabetes	0.000831	0.0106	CbGeAlD
Methotrexate—DHFR—head—gestational diabetes	0.000823	0.0105	CbGeAlD
Methotrexate—Convulsion—Glyburide—gestational diabetes	0.000806	0.0111	CcSEcCtD
Methotrexate—FOLR1—Folate Metabolism—TNF—gestational diabetes	0.000795	0.041	CbGpPWpGaD
Methotrexate—Arthralgia—Glyburide—gestational diabetes	0.000792	0.0109	CcSEcCtD
Methotrexate—Myalgia—Glyburide—gestational diabetes	0.000792	0.0109	CcSEcCtD
Methotrexate—PGD—head—gestational diabetes	0.000791	0.0101	CbGeAlD
Methotrexate—Confusional state—Glyburide—gestational diabetes	0.000765	0.0105	CcSEcCtD
Methotrexate—AOX1—vagina—gestational diabetes	0.000755	0.00963	CbGeAlD
Methotrexate—ABCC4—uterus—gestational diabetes	0.000749	0.00956	CbGeAlD
Methotrexate—Nervous system disorder—Glyburide—gestational diabetes	0.000745	0.0102	CcSEcCtD
Methotrexate—Thrombocytopenia—Glyburide—gestational diabetes	0.000743	0.0102	CcSEcCtD
Methotrexate—SLC16A1—head—gestational diabetes	0.000739	0.00942	CbGeAlD
Methotrexate—ABCC10—vagina—gestational diabetes	0.000734	0.00937	CbGeAlD
Methotrexate—Hyperhidrosis—Glyburide—gestational diabetes	0.000734	0.0101	CcSEcCtD
Methotrexate—ABCC4—adipose tissue—gestational diabetes	0.000733	0.00935	CbGeAlD
Methotrexate—Anorexia—Glyburide—gestational diabetes	0.000724	0.00995	CcSEcCtD
Methotrexate—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.000715	0.0369	CbGpPWpGaD
Methotrexate—Hypotension—Glyburide—gestational diabetes	0.000709	0.00976	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000692	0.00951	CcSEcCtD
Methotrexate—ABCC3—head—gestational diabetes	0.000682	0.0087	CbGeAlD
Methotrexate—Paraesthesia—Glyburide—gestational diabetes	0.000682	0.00938	CcSEcCtD
Methotrexate—Dyspnoea—Glyburide—gestational diabetes	0.000677	0.00931	CcSEcCtD
Methotrexate—Dyspepsia—Glyburide—gestational diabetes	0.000668	0.00919	CcSEcCtD
Methotrexate—Decreased appetite—Glyburide—gestational diabetes	0.00066	0.00908	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000655	0.00901	CcSEcCtD
Methotrexate—ABCC1—uterus—gestational diabetes	0.000639	0.00815	CbGeAlD
Methotrexate—Feeling abnormal—Glyburide—gestational diabetes	0.000626	0.0086	CcSEcCtD
Methotrexate—ABCC1—adipose tissue—gestational diabetes	0.000625	0.00797	CbGeAlD
Methotrexate—Gastrointestinal pain—Glyburide—gestational diabetes	0.000621	0.00854	CcSEcCtD
Methotrexate—Urticaria—Glyburide—gestational diabetes	0.000603	0.0083	CcSEcCtD
Methotrexate—Abdominal pain—Glyburide—gestational diabetes	0.0006	0.00825	CcSEcCtD
Methotrexate—SLCO1A2—head—gestational diabetes	0.000585	0.00746	CbGeAlD
Methotrexate—ABCC4—head—gestational diabetes	0.000563	0.00718	CbGeAlD
Methotrexate—Hypersensitivity—Glyburide—gestational diabetes	0.000559	0.00769	CcSEcCtD
Methotrexate—SLC22A8—head—gestational diabetes	0.000558	0.00712	CbGeAlD
Methotrexate—Asthenia—Glyburide—gestational diabetes	0.000545	0.00749	CcSEcCtD
Methotrexate—Pruritus—Glyburide—gestational diabetes	0.000537	0.00739	CcSEcCtD
Methotrexate—ABCG2—uterus—gestational diabetes	0.000529	0.00675	CbGeAlD
Methotrexate—ABCC1—vagina—gestational diabetes	0.000519	0.00663	CbGeAlD
Methotrexate—Diarrhoea—Glyburide—gestational diabetes	0.000519	0.00714	CcSEcCtD
Methotrexate—ABCG2—adipose tissue—gestational diabetes	0.000517	0.0066	CbGeAlD
Methotrexate—AOX1—Tryptophan metabolism—CYP19A1—gestational diabetes	0.00051	0.0263	CbGpPWpGaD
Methotrexate—Vomiting—Glyburide—gestational diabetes	0.000483	0.00664	CcSEcCtD
Methotrexate—Rash—Glyburide—gestational diabetes	0.000479	0.00658	CcSEcCtD
Methotrexate—Dermatitis—Glyburide—gestational diabetes	0.000478	0.00658	CcSEcCtD
Methotrexate—Headache—Glyburide—gestational diabetes	0.000476	0.00654	CcSEcCtD
Methotrexate—Nausea—Glyburide—gestational diabetes	0.000451	0.0062	CcSEcCtD
Methotrexate—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.000432	0.0222	CbGpPWpGaD
Methotrexate—ABCG2—vagina—gestational diabetes	0.00043	0.00549	CbGeAlD
Methotrexate—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.000421	0.0217	CbGpPWpGaD
Methotrexate—ABCB1—islet of Langerhans—gestational diabetes	0.0004	0.0051	CbGeAlD
Methotrexate—ABCB1—embryo—gestational diabetes	0.000387	0.00494	CbGeAlD
Methotrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.000383	0.0198	CbGpPWpGaD
Methotrexate—SLC19A1—Folate Metabolism—TNF—gestational diabetes	0.000317	0.0163	CbGpPWpGaD
Methotrexate—SLCO3A1—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000281	0.0145	CbGpPWpGaD
Methotrexate—PGD—Carbohydrate metabolism—GCK—gestational diabetes	0.000272	0.014	CbGpPWpGaD
Methotrexate—SLCO4C1—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000268	0.0138	CbGpPWpGaD
Methotrexate—ABCB1—uterus—gestational diabetes	0.000261	0.00333	CbGeAlD
Methotrexate—ABCB1—adipose tissue—gestational diabetes	0.000255	0.00325	CbGeAlD
Methotrexate—ABCG2—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000237	0.0122	CbGpPWpGaD
Methotrexate—ABCC11—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000227	0.0117	CbGpPWpGaD
Methotrexate—SLCO1C1—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000224	0.0116	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—GGCT—gestational diabetes	0.000223	0.0115	CbGpPWpGaD
Methotrexate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.000217	0.0112	CbGpPWpGaD
Methotrexate—ABCB1—vagina—gestational diabetes	0.000212	0.00271	CbGeAlD
Methotrexate—SLC46A1—Folate Metabolism—TNF—gestational diabetes	0.00021	0.0108	CbGpPWpGaD
Methotrexate—ALB—FOXA2 and FOXA3 transcription factor networks—GCK—gestational diabetes	0.000202	0.0104	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—MTNR1B—gestational diabetes	0.000196	0.0101	CbGpPWpGaD
Methotrexate—ABCB1—head—gestational diabetes	0.000196	0.0025	CbGeAlD
Methotrexate—SLC19A1—Metabolism—GLS2—gestational diabetes	0.000195	0.0101	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—GGCT—gestational diabetes	0.00019	0.0098	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—GGCT—gestational diabetes	0.00019	0.0098	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—NAMPT—gestational diabetes	0.000171	0.00883	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—GLS2—gestational diabetes	0.000166	0.00856	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—GLS2—gestational diabetes	0.000166	0.00856	CbGpPWpGaD
Methotrexate—MTHFR—Vitamin B12 Metabolism—TNF—gestational diabetes	0.000156	0.00802	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—GCK—gestational diabetes	0.00015	0.00775	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.00015	0.00775	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—GGCT—gestational diabetes	0.000148	0.00763	CbGpPWpGaD
Methotrexate—SLC22A11—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000147	0.0076	CbGpPWpGaD
Methotrexate—SLC16A1—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000145	0.00745	CbGpPWpGaD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000143	0.00735	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—RBP4—gestational diabetes	0.000142	0.00734	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.00014	0.00722	CbGpPWpGaD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000136	0.00701	CbGpPWpGaD
Methotrexate—PGD—Metabolism—GGCT—gestational diabetes	0.000135	0.00698	CbGpPWpGaD
Methotrexate—SLC22A7—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000134	0.0069	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—GLS2—gestational diabetes	0.000129	0.00667	CbGpPWpGaD
Methotrexate—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000128	0.0066	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—NAMPT—gestational diabetes	0.000128	0.00659	CbGpPWpGaD
Methotrexate—SLCO1B3—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000127	0.00655	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—GCK—gestational diabetes	0.000127	0.00655	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—TNF—gestational diabetes	0.000127	0.00652	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000126	0.0065	CbGpPWpGaD
Methotrexate—FPGS—Disease—RBP4—gestational diabetes	0.000121	0.00625	CbGpPWpGaD
Methotrexate—ABCG2—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000121	0.00624	CbGpPWpGaD
Methotrexate—PGD—Metabolism—GLS2—gestational diabetes	0.000118	0.0061	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000114	0.00588	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—TNF—gestational diabetes	0.000112	0.0058	CbGpPWpGaD
Methotrexate—SLC22A8—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000112	0.0058	CbGpPWpGaD
Methotrexate—FPGS—Disease—NAMPT—gestational diabetes	0.000109	0.0056	CbGpPWpGaD
Methotrexate—FPGS—Disease—GCK—gestational diabetes	0.000108	0.00557	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—NAMPT—gestational diabetes	0.000107	0.00552	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—GCK—gestational diabetes	0.000106	0.00548	CbGpPWpGaD
Methotrexate—MTHFR—Selenium Micronutrient Network—TNF—gestational diabetes	0.000101	0.00518	CbGpPWpGaD
Methotrexate—SLCO1A2—SLC-mediated transmembrane transport—GCK—gestational diabetes	9.98e-05	0.00515	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—RBP4—gestational diabetes	9.44e-05	0.00487	CbGpPWpGaD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—GCK—gestational diabetes	9.38e-05	0.00484	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—NAMPT—gestational diabetes	9.1e-05	0.00469	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—NAMPT—gestational diabetes	9.1e-05	0.00469	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—GCK—gestational diabetes	9.04e-05	0.00466	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—GCK—gestational diabetes	9.04e-05	0.00466	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GGCT—gestational diabetes	8.93e-05	0.0046	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GGCT—gestational diabetes	8.72e-05	0.0045	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—LEP—gestational diabetes	8.7e-05	0.00449	CbGpPWpGaD
Methotrexate—PGD—Disease—RBP4—gestational diabetes	8.63e-05	0.00445	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—GCK—gestational diabetes	8.54e-05	0.0044	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NAMPT—gestational diabetes	8.47e-05	0.00436	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—GCK—gestational diabetes	8.41e-05	0.00434	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GGCT—gestational diabetes	7.94e-05	0.00409	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GLS2—gestational diabetes	7.81e-05	0.00402	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—CYP19A1—gestational diabetes	7.78e-05	0.00401	CbGpPWpGaD
Methotrexate—PGD—Disease—NAMPT—gestational diabetes	7.74e-05	0.00399	CbGpPWpGaD
Methotrexate—PGD—Disease—GCK—gestational diabetes	7.69e-05	0.00397	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GLS2—gestational diabetes	7.63e-05	0.00393	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—GCK—gestational diabetes	7.49e-05	0.00386	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—GCK—gestational diabetes	7.35e-05	0.00379	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GGCT—gestational diabetes	7.23e-05	0.00373	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—NAMPT—gestational diabetes	7.09e-05	0.00365	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—GCK—gestational diabetes	7.05e-05	0.00363	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GLS2—gestational diabetes	6.94e-05	0.00358	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GGCT—gestational diabetes	6.93e-05	0.00357	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	6.89e-05	0.00355	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—GCK—gestational diabetes	6.8e-05	0.0035	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—CYP19A1—gestational diabetes	6.61e-05	0.00341	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—CYP19A1—gestational diabetes	6.61e-05	0.00341	CbGpPWpGaD
Methotrexate—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	6.55e-05	0.00337	CbGpPWpGaD
Methotrexate—PGD—Metabolism—NAMPT—gestational diabetes	6.48e-05	0.00334	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—GCK—gestational diabetes	6.46e-05	0.00333	CbGpPWpGaD
Methotrexate—PGD—Metabolism—GCK—gestational diabetes	6.44e-05	0.00332	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GGCT—gestational diabetes	6.35e-05	0.00328	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GLS2—gestational diabetes	6.32e-05	0.00326	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GLS2—gestational diabetes	6.05e-05	0.00312	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—GCK—gestational diabetes	5.83e-05	0.003	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GGCT—gestational diabetes	5.73e-05	0.00296	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—GCK—gestational diabetes	5.71e-05	0.00294	CbGpPWpGaD
Methotrexate—MTHFR—Disease—RBP4—gestational diabetes	5.7e-05	0.00294	CbGpPWpGaD
Methotrexate—AOX1—Disease—RBP4—gestational diabetes	5.56e-05	0.00287	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GLS2—gestational diabetes	5.55e-05	0.00286	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—GCK—gestational diabetes	5.48e-05	0.00282	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—CYP19A1—gestational diabetes	5.15e-05	0.00266	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NAMPT—gestational diabetes	5.11e-05	0.00263	CbGpPWpGaD
Methotrexate—MTHFR—Disease—GCK—gestational diabetes	5.08e-05	0.00262	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—GCK—gestational diabetes	5.07e-05	0.00261	CbGpPWpGaD
Methotrexate—DHFR—Disease—RBP4—gestational diabetes	5.06e-05	0.00261	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GLS2—gestational diabetes	5.01e-05	0.00258	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GGCT—gestational diabetes	4.99e-05	0.00257	CbGpPWpGaD
Methotrexate—AOX1—Disease—NAMPT—gestational diabetes	4.99e-05	0.00257	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.96e-05	0.00256	CbGpPWpGaD
Methotrexate—AOX1—Disease—GCK—gestational diabetes	4.96e-05	0.00256	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—FGF2—gestational diabetes	4.93e-05	0.00254	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—GCK—gestational diabetes	4.88e-05	0.00251	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—GCK—gestational diabetes	4.77e-05	0.00246	CbGpPWpGaD
Methotrexate—PGD—Metabolism—CYP19A1—gestational diabetes	4.71e-05	0.00243	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—GCK—gestational diabetes	4.62e-05	0.00238	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—GCK—gestational diabetes	4.56e-05	0.00235	CbGpPWpGaD
Methotrexate—DHFR—Disease—NAMPT—gestational diabetes	4.54e-05	0.00234	CbGpPWpGaD
Methotrexate—DHFR—Disease—GCK—gestational diabetes	4.51e-05	0.00233	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GGCT—gestational diabetes	4.49e-05	0.00232	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.48e-05	0.00231	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GLS2—gestational diabetes	4.36e-05	0.00225	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—GCK—gestational diabetes	4.34e-05	0.00224	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—NAMPT—gestational diabetes	4.28e-05	0.00221	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GGCT—gestational diabetes	4.27e-05	0.0022	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GCK—gestational diabetes	4.25e-05	0.00219	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—TNF—gestational diabetes	4.25e-05	0.00219	CbGpPWpGaD
Methotrexate—FPGS—Disease—FGF2—gestational diabetes	4.2e-05	0.00216	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	4.19e-05	0.00216	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NAMPT—gestational diabetes	4.18e-05	0.00215	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GCK—gestational diabetes	4.15e-05	0.00214	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	4.02e-05	0.00207	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GGCT—gestational diabetes	3.95e-05	0.00204	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GLS2—gestational diabetes	3.93e-05	0.00202	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.9e-05	0.00201	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	3.89e-05	0.00201	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NAMPT—gestational diabetes	3.8e-05	0.00196	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GCK—gestational diabetes	3.78e-05	0.00195	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GLS2—gestational diabetes	3.73e-05	0.00192	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.51e-05	0.00181	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NAMPT—gestational diabetes	3.46e-05	0.00178	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TNF—gestational diabetes	3.46e-05	0.00178	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GLS2—gestational diabetes	3.45e-05	0.00178	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GCK—gestational diabetes	3.44e-05	0.00177	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.34e-05	0.00172	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NAMPT—gestational diabetes	3.32e-05	0.00171	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GCK—gestational diabetes	3.3e-05	0.0017	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—FGF2—gestational diabetes	3.27e-05	0.00169	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CYP19A1—gestational diabetes	3.11e-05	0.0016	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NAMPT—gestational diabetes	3.04e-05	0.00157	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CYP19A1—gestational diabetes	3.04e-05	0.00157	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GCK—gestational diabetes	3.02e-05	0.00156	CbGpPWpGaD
Methotrexate—PGD—Disease—FGF2—gestational diabetes	2.99e-05	0.00154	CbGpPWpGaD
Methotrexate—ABCC1—Disease—RBP4—gestational diabetes	2.86e-05	0.00148	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CYP19A1—gestational diabetes	2.76e-05	0.00142	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NAMPT—gestational diabetes	2.75e-05	0.00142	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—gestational diabetes	2.75e-05	0.00142	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GCK—gestational diabetes	2.73e-05	0.00141	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—gestational diabetes	2.62e-05	0.00135	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NAMPT—gestational diabetes	2.57e-05	0.00132	CbGpPWpGaD
Methotrexate—ABCC1—Disease—GCK—gestational diabetes	2.55e-05	0.00132	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CYP19A1—gestational diabetes	2.52e-05	0.0013	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—GCK—gestational diabetes	2.48e-05	0.00128	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GGCT—gestational diabetes	2.44e-05	0.00126	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CYP19A1—gestational diabetes	2.41e-05	0.00124	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NAMPT—gestational diabetes	2.39e-05	0.00123	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GCK—gestational diabetes	2.38e-05	0.00122	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CYP19A1—gestational diabetes	2.21e-05	0.00114	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	2.17e-05	0.00112	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NAMPT—gestational diabetes	2.15e-05	0.00111	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GCK—gestational diabetes	2.14e-05	0.0011	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GGCT—gestational diabetes	2.14e-05	0.0011	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GLS2—gestational diabetes	2.13e-05	0.0011	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	2.13e-05	0.0011	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NAMPT—gestational diabetes	2.04e-05	0.00105	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GCK—gestational diabetes	2.03e-05	0.00105	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CYP19A1—gestational diabetes	1.99e-05	0.00103	CbGpPWpGaD
Methotrexate—MTHFR—Disease—FGF2—gestational diabetes	1.97e-05	0.00102	CbGpPWpGaD
Methotrexate—AOX1—Disease—FGF2—gestational diabetes	1.93e-05	0.000993	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	1.91e-05	0.000982	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NAMPT—gestational diabetes	1.89e-05	0.000976	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GCK—gestational diabetes	1.88e-05	0.00097	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GLS2—gestational diabetes	1.87e-05	0.000963	CbGpPWpGaD
Methotrexate—DHFR—Disease—FGF2—gestational diabetes	1.75e-05	0.000904	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CYP19A1—gestational diabetes	1.74e-05	0.000895	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CYP19A1—gestational diabetes	1.56e-05	0.000806	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CYP19A1—gestational diabetes	1.49e-05	0.000766	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP19A1—gestational diabetes	1.38e-05	0.000709	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	1.29e-05	0.000667	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NAMPT—gestational diabetes	1.17e-05	0.000602	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GCK—gestational diabetes	1.16e-05	0.000598	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NAMPT—gestational diabetes	1.02e-05	0.000528	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GCK—gestational diabetes	1.02e-05	0.000524	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGF2—gestational diabetes	9.92e-06	0.000511	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP19A1—gestational diabetes	8.49e-06	0.000438	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP19A1—gestational diabetes	7.44e-06	0.000383	CbGpPWpGaD
